ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

For ADT Reduced Use

November 5, 2010

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975